Galastri Francisco Leonardo, Valle Leonardo Guedes Moreira, Affonso Breno Boueri, Silva Marcela Juliano, Garcia Rodrigo Gobbo, Junior Milton Rodrigues, Ferraz Leonardo Jose Rolim, de Matos Gustavo Faissol Janot, de la Cruz Scarin Farah Christina, Nasser Felipe
Interventional Medicine Center, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Department of Pneumology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Vasa. 2020 Jun;49(4):333-337. doi: 10.1024/0301-1526/a000880. Epub 2020 May 28.
COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.
新型冠状病毒肺炎（COVID-19）是一种最近发现的与血栓栓塞事件相关的疾病。我们报告一例COVID-19患者发生肺栓塞，经导管直接血栓切除术治疗。一名57岁患者因严重的COVID-19症状就诊于急诊中心，并发生了大面积肺栓塞。该患者接受了导管直接溶栓（CDT）治疗并完全康复。所有重症COVID-19病例均存在与该疾病相关的凝血病，且这是一个动态过程。我们描述了一例在接受充分抗凝治疗的COVID-19患者中发生的大面积/高危肺栓塞病例，该患者接受了经皮介入治疗。对于出现快速临床恶化的COVID-19合并肺栓塞患者，CDT可以作为一种额外的治疗选择。
